1. Home
  2. PRO vs EMBC Comparison

PRO vs EMBC Comparison

Compare PRO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRO
  • EMBC
  • Stock Information
  • Founded
  • PRO 1985
  • EMBC 1924
  • Country
  • PRO United States
  • EMBC United States
  • Employees
  • PRO N/A
  • EMBC N/A
  • Industry
  • PRO EDP Services
  • EMBC Medical/Dental Instruments
  • Sector
  • PRO Technology
  • EMBC Health Care
  • Exchange
  • PRO Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • PRO 898.3M
  • EMBC 719.1M
  • IPO Year
  • PRO 2007
  • EMBC N/A
  • Fundamental
  • Price
  • PRO $17.89
  • EMBC $11.82
  • Analyst Decision
  • PRO Strong Buy
  • EMBC Hold
  • Analyst Count
  • PRO 10
  • EMBC 3
  • Target Price
  • PRO $31.10
  • EMBC $17.67
  • AVG Volume (30 Days)
  • PRO 615.5K
  • EMBC 583.1K
  • Earning Date
  • PRO 05-01-2025
  • EMBC 05-09-2025
  • Dividend Yield
  • PRO N/A
  • EMBC 5.24%
  • EPS Growth
  • PRO N/A
  • EMBC 2.96
  • EPS
  • PRO N/A
  • EMBC 0.99
  • Revenue
  • PRO $330,372,000.00
  • EMBC $1,107,700,000.00
  • Revenue This Year
  • PRO $10.12
  • EMBC N/A
  • Revenue Next Year
  • PRO $10.10
  • EMBC $0.99
  • P/E Ratio
  • PRO N/A
  • EMBC $11.57
  • Revenue Growth
  • PRO 8.78
  • EMBC N/A
  • 52 Week Low
  • PRO $14.81
  • EMBC $10.00
  • 52 Week High
  • PRO $34.54
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • PRO 48.61
  • EMBC 43.94
  • Support Level
  • PRO $15.22
  • EMBC $10.83
  • Resistance Level
  • PRO $17.74
  • EMBC $11.85
  • Average True Range (ATR)
  • PRO 0.89
  • EMBC 0.67
  • MACD
  • PRO 0.35
  • EMBC 0.06
  • Stochastic Oscillator
  • PRO 99.68
  • EMBC 49.18

About PRO PROS Holdings Inc.

Pros Holdings Inc. is a provider of cloud-based revenue and profit realization software solutions to business-to-business and business-to-consumer companies. Its solutions assist customers in growing revenue, modernizing business processes, and supporting profitability by leveraging prescriptive analytics and data science-based decision-making technology. The company's solutions enable buyers to move fluidly across its customers' direct sales, partner, online, mobile, and emerging channels with personalized experiences. The firm generates revenue in the United States, Europe, Africa, Asia-Pacific, and Middle East regions.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: